Viemed reports record Q4 revenue $50.7M (+35% YoY); net income up 43%

VIEMED HEALTHCARE, INC.

Q4 2023 revenue $50.7M, up 35% from $37.5M in Q4 2022; full-year revenue $183.0M, up 32%.
Q4 net income $3.5M (+43% YoY); full-year net income $10.2M (+65% YoY), seventh consecutive profitable year.
Adjusted EBITDA for Q4 $12.8M; full-year record $43.1M.
Company highlights record quarterly and annual net revenues driven by respiratory care services growth.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

VIEMED HEALTHCARE, INC. reported the three months and year ended December 31, 2023 results: revenue $50.7 million, net income $3.5 million.

Period: the three months and year ended December 31, 2023
Revenue: $50.7 million
Net income: $3.5 million
Result: reported results

Exact text from the filing

and year ended December 31, 2023. Operational highlights (all dollar amounts are USD): • Net revenues for the quarter ended December 31, 2023 reached a new Company record of $50.7 million representing an increase of $13.2 million, or 35%, over net revenues reported for the comparable quarter ended December 31, 2022. Total net revenues for the year ended December

View on SEC.gov

710 earnings releases filed in the last 30 days. Browse all earnings releases →

VIEMED HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001729149-24-000075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.